Salvaged allogeneic hematopoietic stem cell transplantation for pediatric chemotherapy refractory acute leukemia.

about

Salvaged allogeneic hematopoietic stem cell transplantation for pediatric chemotherapy refractory acute leukemia.

Item

http://www.wikidata.org/entity/Q48505253

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Salvaged allogeneic hematopoie ...... apy refractory acute leukemia.

@en

Salvaged allogeneic hematopoie ...... apy refractory acute leukemia.

@nl

type

Item

label

Salvaged allogeneic hematopoie ...... apy refractory acute leukemia.

@en

Salvaged allogeneic hematopoie ...... apy refractory acute leukemia.

@nl

prefLabel

Salvaged allogeneic hematopoie ...... apy refractory acute leukemia.

@en

Salvaged allogeneic hematopoie ...... apy refractory acute leukemia.

@nl

P1476

Salvaged allogeneic hematopoie ...... apy refractory acute leukemia.

@en

P2093

Fan Yang

http://www.w3.org/2001/XMLSchema#string

Haoyu Cheng

http://www.w3.org/2001/XMLSchema#string

Jiangying Gu

http://www.w3.org/2001/XMLSchema#string

Jingbo Wang

http://www.w3.org/2001/XMLSchema#string

Junbao He

http://www.w3.org/2001/XMLSchema#string

Lei Yuan

http://www.w3.org/2001/XMLSchema#string

Song Xue

http://www.w3.org/2001/XMLSchema#string

Weijie Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaocan Wang

http://www.w3.org/2001/XMLSchema#string

Xinhong Fei

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report

Donor parity no longer a barrier for female-to-male hematopoietic stem cell transplantation.

Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia.

Cell kinetics in acute lymphoblastic leukaemia: comparative analysis between adults and children

Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant.

P304

3143-3159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22809

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29423036

http://www.w3.org/2001/XMLSchema#string

P932

5790453

http://www.w3.org/2001/XMLSchema#string